[London, 6 June 2024] – With deep, hassle-free, integration, Augnito is enabling continued transformation in radiology and supporting key solutions that will be showcased at UKIO 2024.
Taking place from 10th-12th June 2024 in Liverpool, the UK Imaging and Oncology (UKIO) congress is where leaders from across radiology come together to share best practice, discuss trends, undertake professional development, and learn about the latest state-of-the-art equipment and technology. The 2024 event will focus on the theme of ‘Vision and Values: Putting People First’.
Thanks to robust partnerships and extensive integration with leading platforms, Augnito speech recognition from Scribetech will be present at the event for the fourth year running.
“Nothi
ng is more important to us than elevating fields across healthcare, and radiology is a particular focus,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito. “Augnito Spectra, our own highly convenient frontend across desktop and mobile, is part of this approach, but integration is equally important. Technology providers understand the potential of speech recognition as an accessible way for healthcare to leverage the potential of AI. Our partnerships with award-winning providers using Augnito Voice Services to speech enable their platforms is key to how, together, we can bring the benefits of speech recognition to more radiologists.”
One of the solutions carrying Augnito Voice Services embedded inside is Intelerad’s InSight PACS, adopted by over 250 NHS and private healthcare providers across the UK and Ireland. In February 2024, InSight PACS was recognised as a 2024 Best in KLAS: Global Software Report award winner. Crucially, this award was based on feedback from the solution’s users – the people who rely on radiology reporting technology every day.
Austin stated: “Clinical system developers and cloud imaging solution providers appreciate Augnito for its API and SDK allowing them to seamlessly add Voice Services to their offering. We’ve taken one-of-a-kind speech recognition, developed in partnership with clinicians, and made it easy to integrate into any existing diagnostics and radiology reporting platform. But what drives us is the response from radiologists. People have reported significant time savings, faster reports, and increased accuracy – all these benefits lead to smoother patient journeys and better outcomes. That’s what matters.”
Augnito is also integrated into Hexarad: Radiology Technology Innovator of the Year in the M&A Today Global Awards 2024. Hexarad was also awarded the Silver HSJ Partnership Award for Diagnostics Project of the Year for its partnership with the North West Anglia NHS Foundation Trust. This project led to estimated time savings of up to 80 minutes per patient. Meanwhile, teleradiologists reporting on behalf of the trust received images within 25 minutes compared to 45 minutes using the previous system.
Representatives from these leading imaging solutions award winners will be attending UKIO 2024, (Hexarad), and exhibiting (Intelerad) alongside other high profile Scribetech partners using Augnito to speech-enable their systems. Exhibitors include Aptvision Ltd – with their e-referral portal, delivering better patient outcomes and reducing workloads for medical staff, CIMAR UK Ltd – who has recently joined forces with NHS England to deliver the AI Development Platform Pilot at Royal Surrey NHS Foundation Trust that will then enable the deployment of AI in medical imaging across the NHS, Fujifilm Healthcare UK – has integrated Augnito into its Universal Reporting module and will be showing this at UKIO, as well as new ultrasound imaging innovations and live demonstrations on its DeepInsight AI technology, Magentus – with a new Managing Director at their UK helm and a team supporting more than 25 million imaging events each year across 700+ locations with its Cris Radiology Information System, and OpenRad Services UK Ltd – showcasing its cloud-based Augnito speech-enabled remote reporting platform that includes the functionalities of a PACS, RIS and diagnostic 3D visualisation as distinct subscription packages with secure access from anywhere and from any device.
This significant presence at UKIO reflects the continued growth of Augnito AI powered speech recognition across radiology.
Scribetech is also a member of AXREM, the UK trade association for suppliers of imaging and healthcare equipment. This gives the company insight into the current and emerging needs of radiologists and imaging professionals and helps ensure that its voice-driven AI powered and cloud based solution, Augnito, remains relevant, impactful and evolving in pace with demand.
“This will be the fourth year running, since launching Augnito technology, that it is being shown at UKIO through our partners,” added Austin. “And while Scribetech has been an approved NHS solutions provider for over two decades, we brought Augnito to the UK market as a disruptive technology because our vision was to democratise the use of speech recognition across the continuum of care. We knew Augnito provided the value advantage – a better and more cost effective way for healthcare professionals to leverage the cloud and AI, to easily transform their patient data workflows. Now, 30 months later, we’re supporting more than 2,000 UK radiologists who have switched to Augnito – through our partnerships – and many others directly. We couldn’t agree more with this year’s UKIO theme and message ‘Vision and Values: Putting People First’. The positive effect that the impact Augnito is having on radiologists, and on patient imaging and diagnostics reporting speaks for itself. ”
ENDS
For media enquiries, please contact [email protected]
Notes to editors
All company names and product names listed in this press release are trademarks and registered trademarks of their respective owners.
About Scribetech (UK) Ltd and Augnito
Scribetech (UK) Ltd is a clinical solutions innovator and official distributor of Augnito products in the UK and Ireland. The company co-developed Augnito with its sister company Augnito India Private Ltd fusing 20 years of highly accurate and secure transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own Deep Neural Network speech recognition engine with advanced voice AI technology. Augnito provides a secure, cloud-based, voice-driven AI clinical speech recognition product suite, offering fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings cost effective, seamless speech recognition to daily workflows and third-party clinical systems, quickly turning medical information into documentation that makes healthcare intelligence compliant and accessible where it is needed.
[London, 30 April 2024] – Strengthening its position as an innovator in the imaging community, Scribetech has joined AXREM, the UK trade association for suppliers of imaging and healthcare IT equipment.
As UK healthcare continues its process of innovation, transformation and digitalisation, collaboration is vital. IT and equipment providers have an important role to play in addressing the emerging needs of healthcare professionals, responding to market changes, and steering the sector in-line with regulatory and compliance expectations.
To play a more active role in this process and champion sophisticated clinical speech recognition solutions in diagnostics and imaging, Scribetech, creator of Augnito, has joined AXREM as a new member.
“We know speech recognition has been instrumental in changing how radiologists work, since their early adoption of the technology in the 1980’s; we also know how today’s advanced and highly accurate speech recognition, powered by AI, has the ability to really help healthcare transform,” stated Shiraz Austin, Managing Director at Scribetech (UK) Ltd and Co-Founder of Augnito. “With an industry leading solution offering an easy and efficient way to transcribe and digitalise imaging and diagnostics reporting as well as full integration with clinical systems, it’s crucial that we maximise our engagement with the radiology community—not just the healthcare professionals we support, but other technology providers and regulators. Our membership of AXREM reflects our commitment to leading the conversation around the future of imaging and healthcare.”
Established as the Association of X-Ray Equipment Manufacturers, AXREM has evolved over the past few years as the nature of diagnostic imaging equipment has changed. Today, AXREM is the largest UK trade association for suppliers of diagnostic imaging, radiotherapy and patient monitoring equipment, bringing together over 60 member companies. AXREM represents almost all of the UK market and, as a result, is an influential voice to represent its members’ views at every level of healthcare.
AXREM membership provides industry validation for Augnito, increasing its credibility as a reliable, high-quality solution in the medical imaging market. Additionally, membership also opens up a number of significant strategic benefits for Scribetech as part of the imaging community.
AXREM members receive regular industry insights and expertise, allowing Augnito to remain relevant to the real requirements of radiologists. Members can also take part in opportunities to network and collaborate, opening doors to new ways to integrate leading technology with Augnito and vice versa, as well as forums to share best practice.
Together, these membership benefits increase Scribetech’s ability to position Augnito strategically in the marketplace, drive growth opportunities, foster innovation, and strengthen its competitive advantage.
Austin added: “AXREM and its other member organisations share our priorities, ambitions and the ultimate aim of improving patient care. As a member, we’re forging a closer connection to the rest of the radiology and imaging community. This includes consultants, radiologists and radiographers, but also technology providers who can benefit from how easily Augnito can be integrated into their solutions. As a result, we’re able to bring the benefits of accurate, AI-powered speech recognition to more solutions and existing workflows.”
Augnito offers 99.9% accurate speech recognition in dedicated software, including desktop apps, browser-based interfaces, and mobile apps. Augnito was also developed with connectivity and integration in mind, including a comprehensive API and SDK to add native speech to existing systems including EPRs.
Austin concluded: “We’re looking forward to cementing our position as the leading provider of speech recognition in radiology and becoming part of the AXREM ecosystem.”
ENDS
Notes to editors
About Augnito from Scribetech (UK) Ltd
Augnito is a secure, cloud-based, AI-driven clinical speech recognition product suite. It offers fast, easy ways to capture live clinical data on any device with 99% accuracy, support for multiple medical specialities, and no need for voice profile training. Augnito brings seamless speech recognition to daily workflows and third-party clinical systems, turning medical information into clinical documentation and making healthcare intelligence securely accessible everywhere.
Augnito was co-developed by Scribetech, a clinical voice solutions innovator, fusing 20 years of transcription and digital dictation services to the NHS, speech-to-text, and clinical coding solutions for the healthcare sector, and its own speech recognition engine with advanced voice AI technology.
Visit www.scribetech.co.uk for more details. For media enquiries, please contact [email protected].
About AXREM
AXREM’s member companies supply most of the diagnostic medical imaging and radiotherapy equipment installed in UK hospitals. They work with Consultant Radiologists, Radiographers and Practitioners, Oncologists, and a wide range of healthcare professionals in delivering healthcare to patients using our technologies.
Our members have unique knowledge, experience and insight into the workflow and challenges faced by healthcare professionals on a day-to-day basis, which enables us to develop and offer innovative solutions to improve the speed and quality of diagnostic procedures and treatments with our aim of improving patient care. Although our members operate in a highly competitive commercial environment and in strict conformity with UK laws and regulations, certain issues such as this require focus and resolution on an industry-wide basis.
For further information about this press release please contact AXREM Chief Executive Officer – Sally Edgington
AXREM, Rotherwick House, 3 Thomas More Street, London, E1W 1YZ
E [email protected] ¦ T 07717 058649 ¦ www.axrem.org.uk